As of November 2024, ImmuneOnco Biopharmaceuticals has a market cap of $165.98M. This makes ImmuneOnco Biopharmaceuticals the world's 18463th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $530.79M | -39.46% |
2023 | $876.84M | - |